RxDoctor Payments Data

Ihab Hajjar, MD

Neurology · Dallas, TXNPI 1891723912

Payments from drug & device makers

$292,050in general payments, 2019–2025

Across 36 payments — averaging $8112.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$250K
  • Eisai Inc.$42K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.30$250,375
Eisai Inc.6$41,675

How this compares

$292,050 in reported general payments places this provider in the 90th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas

Medicare billing

Part B allowed, 2024
$8,853
Medicare patients
24
Services billed
68

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AdlarityDonepezil Hcl14$6,715
Donepezil Hcl58$557
Memantine Hcl ErMemantine Hcl13$433
Trazodone Hcl16$207
Escitalopram Oxalate14$151

Paid to pharmacies, not to this prescriber.

Other neurology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →